MD Biosciences

1000 West Gate Drive Suite 162
ST Paul, MN 55114

About MD Biosciences

Products and preclinical contract research (CRO) for inflammation, neurology, cardiovascular and pain. Our approach is one of complete flexibility. Test items can be evaluated as a strategic and systematic process or as a stand alone service depending on where in the development phase a test item is. MD Biosciences staff can operate as an external research group for the client, capable of initiating ideas, proposing projects, bringing insight and observations We provide a customized, efficient and systematic approach to discovery aimed at reducing late phase failures.

Services capabilities:
- in vitro screening for compound profiling studies
- in vivo and in vitro mechanism of action platforms for therapeutic targeting or repositioning strategies
- Efficacy and proof-of-concept studies
- Biomarker and gene expression analysis
- Imaging capabilities
- Histology and IHC analysis

Products include:
- Disease induction reagents
- ELISA and assay kits
- Proteins and Antibodies

Competitors of MD Biosciences



Ardena is your one-source partner to help you navigate the drug development process from molecule to clinic. We offer an integrated, flexible service encompassing drug substance production, dosage form manufacture, clinical logistics, bioanalysis and dossier development. We are also at the... Read More

Ceadarburg Hauser Pharmaceuticals

Cedarburg Hauser Pharmaceutical Services, Inc. is a world leader in the extraction, isolation, purification and synthetic modification of natural products from plant, marine and microbial sources. Cedarburg Hauser Pharmaceutical Services, Inc. provides research, process development, analytical... Read More

QPS Holdings, LLC

QPS is a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services since 1995. Our mission is to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services. An award-winning leader focused on... Read More